Learn More
Medchemexpress LLC NY-ESO-1 (157-165) peptide | 202815-17-6 | 99.75% | 1094.35 | 10 MG

Supplier: Medchemexpress LLC HYP1049310MG
NY-ESO-1 (157-165) peptide is a peptide fragment derived from the NY-ESO-1 protein. It has the ability to activate the immune system, particularly in individuals who are HLA-A2 positive. This activation occurs as CD8+ T cells recognize the peptide, leading to an immune response. The NY-ESO-1 (157-165) peptide is present in various tumors, making it a potential target for tumor immunotherapy.
- Peptide fragment from NY-ESO-1 protein.
- Activates the immune system.
- Recognized by CD8+ T cells in HLA-A2 positive individuals.
- Triggers an immune response.
- Expressed in various tumors.
- Can be used as a target for tumor immunotherapy.
- Highly immunogenic epitope of NY-ESO-1.
- Can induce spontaneous or vaccine-induced T cell immune responses.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.